Entera Bio - ENTX Net Sales Margin

enterabio.com (ENTX) - corporate logo

Entera Bio Ltd. (ENTX) generates revenue through the licensing of systems that convert injections into tablets, receiving royalties. The net profitability level of sales reflects current dynamics, where the value of 0.00 characterizes this level. Growth is driven by successes in protein delivery and deals with industry behemoths, although operational activities currently rely on existing cash reserves.

enterabio.com (ENTX) Net Profit Rate: for the period 07/04/2022 - 11/19/2026

enterabio.com (ENTX) - metric breakdowns and financial figures

- share price and consensus valuation forecast:
Fundamental valuation:Entera Bio - ENTX
Finished products of Entera Bio Ltd.

Net profit margin measures the portion of profit in every dollar of revenue, determining the business's actual margin of safety. It is critical for investors to track this metric's dynamics to identify hidden risks prior to the publication of quarterly reports. By analyzing actual sales margins, one can assess a company's resilience to pessimistic scenarios. For Entera Bio Ltd. (ENTX), such stability is maintained through the optimization of personnel costs. The use of contractors and stock option incentives for scientists minimizes operating expenses.

Competitors of Entera Bio Ltd. (ENTX)

HLN: Net Sales Margin|Net Return on Sales KVUE|Net Margin veronapharma.com|Net Return on Sales MENS (Jyong Biotech Corp)|Net Margin Ligand (LGND)|Net Sales Margin amneal.com (AMRX)|Net Sales Margin PRGO (perrigo.com)|Alvotech SA (ALVO) - Net Margin|Liquidia Inc. - Net Sales Margin|Net Profitability Margin Galapagos Corp (GLPG)|ANI Pharmaceuticals (ANIP) - Net Margin|Net Return on Sales MNKD|Net Margin Amphastar Pharmaceuticals, Inc.|Pacira Pharmaceuticals (PCRX) - Company Sales Margin|Net Sales Margin SPRY|TBPH - Net Margin|Aquestive Pharma - Return on Sales by Net Profit|Net Sales Margin scpharmaceuticals.com SCPH|Tectonic - Net Sales Margin|TNXP - Net Sales Margin|SXTC: Net Sales Margin|Eupraxia Pharma - Net Profit Rate|BHST (bioharvest.com) - Net Sales Margin|Net Return on Sales EXOZ (invizyne.com)|Net Sales Margin ORMP|MindWalk Holdings Inc. - Net Return on Sales|Net Sales Margin ABVC (ABVC BioPharma Inc)|CPIX - Return on Sales by Net Profit|Quantum BioPharma Corp - Net Sales Margin|FGEN (fibrogen.com) - Net Return on Sales|TELO (Telomir Pharmaceuticals) - Return on Sales by Net Profit|Rani Therapeutics Holdings - Net Profit Rate|Return on Sales by Net Profit SNYR|Net Margin rallybio.com RLYB|Net Sales Margin LEXX|PULM (Pulmatrix, Inc.) - Net Profit Rate|Pheton Holdings - Return on Sales by Net Profit|Net Sales Margin Aptorum Group Limited APM|LYRA: Return on Sales by Net Profit|IBO: Net Margin|TNFA: Net Sales Margin|YCBD: Company Net Profitability|Net Margin PainReform Ltd|CYTO (altamiratherapeutics.com) - Company Net Profitability|Net Sales Margin LIPO|OPTN - Net Margin|Net Margin pieris.com PIRS|Net Profit Rate PROC|PTPI - Net Margin|Qilian International Holding (QLI) - Return on Sales by Net Profit|SLRN: Net Sales Margin|Return on Sales by Net Profit TFF Pharma